Publication:
Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib

Simple item page
dc.contributor.authorNoppadon Kongsuphonen_US
dc.contributor.authorMaturos Soukavanitchen_US
dc.contributor.authorNoramon Teeraaumpornpunten_US
dc.contributor.authorJitprapa Konmunen_US
dc.contributor.authorTouch Ativitavasen_US
dc.contributor.authorNuttapong Ngamphaiboonen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2020-01-27T09:30:31Z
dc.date.available2020-01-27T09:30:31Z
dc.date.issued2019-09-15en_US
dc.identifier.citationJournal of Gastrointestinal Cancer. Vol.50, No.3 (2019), 601-603en_US
dc.identifier.doi10.1007/s12029-018-0067-6en_US
dc.identifier.issn19416636en_US
dc.identifier.issn19416628en_US
dc.identifier.other2-s2.0-85041627744en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/51413
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041627744&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleMulti-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafeniben_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041627744&origin=inwarden_US

Files

Collections

Scopus 2019